# Hemex

Hemex is an Asset Manager based in Liestal, Switzerland.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Liestal, Switzerland
- **Region:** Europe
- **Address:** Kasernenstrasse 30, 4410 Liestal, Switzerland
- **Founded:** 2011
- **Assets under management:** Undisclosed
- **Website:** www.hemex.eu
- **LinkedIn:** https://www.linkedin.com/company/hemex-ag

## Regulatory record

- **Reports private funds:** No

## About

HEMEX is an integrated Clinical Research, Development, and Manufacturing Organization (CRDMO) providing end-to-end support for biotech, pharmaceutical, and medical devices programs, from early discovery to commercial-scale manufacturing, ensuring scientific rigor and regulatory compliance. It connects every stage of development into one efficient pathway to market. Its services include Medtech, IVD, Digital Health, Pharma & Biotech, First-in-Human & PK Studies, Site & Patient Recruitment, and Imaging services.

## Sectors

- Digital Health
- Healthcare Services

## People

- Franziska Stemmler — Co-founder and CEO
- Pascal Winnen — Co-founder and Managing Director EU

## Questions

### How does Hemex source proprietary deal flow?

Hemex sources primarily through its deep integration with the European life-science cluster ecosystem. The firm holds memberships in the Swiss Biotech Association, BioRN, HealthTech Cluster Switzerland, and the BEAM Alliance, giving it early visibility into academic spin-outs and pre-commercial ventures emerging from the Basel-Zurich-Rhine-Neckar corridor. Its collaborative project work with the Swiss Tropical and Public Health Institute provides an additional sourcing channel into global-health innovation.

### What investment stage does Hemex typically target?

The firm targets the earliest commercial stages — start-up and early seed — with a focus on ventures that are advancing toward clinical proof-of-concept. Its portfolio companies operate at the intersection of academic research and first regulatory milestones, particularly in diagnostics, medical devices, and novel therapeutic platforms.

## Related profiles

- [Helvetica Capital](https://altss.com/profile/helvetica-capital)
- [Hemingway Capital](https://altss.com/profile/hemingway-capital)

---

Last updated: 2026-08-11T15:06:57.816Z

Canonical page: https://altss.com/profile/hemex-ag

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology